Magellan Diagnostics News Today

BOSTON — A Massachusetts company will pay $42 million to settle claims that it concealed a medical device malfunction that produced inaccurately low lead test results for tens of thousands

BOSTON — A Massachusetts company will pay $42 million to settle claims that it concealed a medical device malfunction that produced inaccurately low lead test results for tens of thousands

By Nate Raymond BOSTON (Reuters) - A medical device company has agreed to pay $42 million and plead guilty to resolve U.S. charges that it concealed a ...

Magellan Diagnostics admits that it misled customers and the FDA about a device malfunction that produced inaccurately low results in lead level blood tests for potentially tens of thousands of children and other patients.

BOSTON — A Massachusetts company will pay $42 million to settle claims that it concealed a medical device malfunction that produced inaccurately low lead test results for tens of thousands

BOSTON — A medical device company headquartered in Billerica, Mass., has agreed to pay $42 million and plead guilty to resolve charges that it concealed a malfunction in its lead-testing

This weekly news program, hosted by partner Sam Bernstein, covers recent legal and compliance developments for medical device companies, including…

The Healthtech Times is a weekly newsletter covering healthtech news from Canada and around the globe.

(CHILDREN'S HEALTH DEFENSE) – Three former executives of a Massachusetts-based health diagnostics company deliberately concealed a problem with the company’s lead-testing devices that produced inaccurately low results for tens of thousands of children, according to federal prosecutors. Amy Winslow, Reba Daoust and Mohammad Hossein Maleknia — all former executives at Magellan Diagnostics — “deceived customers…

Three former executives of a company that makes machines that test lead levels in humans deliberately concealed a problem with the devices that produced